|
|
 |
|
Viewing report
|
|
 |
 |
Cardiology Drug Licensing Opportunities, 2002
ADIS, Jan 2002, Pages: 193
This report is intended to provide a useful resource to professionals in research and development (R&D), marketing, business development, licensing, and strategic planning who are currently, or anticipate being involved, in the discovery, development, licensing, and/or marketing of therapeutics for the treatment of acute coronary syndrome (ACS) [thrombosis, acute myocardial infarction (MI), unstable angina (UA)], stable angina (SA), arrhythmia, atherosclerosis/hyperlipidemia, congestive heart failure (CHF), hypertension and restenosis.
Customers who bought this item also bought
Cardiovascular Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Cardiovascular Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy
Strastegic Perspectives 2001: Diabetic Hypertension - Towards Aggressive, Individual and Holistic Treatment Strategies
Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs
Atherosclerosis: Strategic Audit of Marketplace Activity Issues and Implications
Drugs of Tomorrow 2001: Anticoagulants - A pipeline flowing with future blockbusters
Drugs of Tomorrow 2001: Hypertension - The Mounting Pressures Facing New Compounds
Cardiology, Competitive Strategies, 2002
Drugs of Tomorrow 2001: Diabetes
Devices and Drugs of Tomorrow 2002: Prevention and Treatment of Coronary Restenosis
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed
|
 |
|
|